←Back to Expert Scholars
Translational Medicine / 转化医学Chemoprevention, Breast Cancer
Jack Cuzick
PhD
🏢Queen Mary University of London🌐UK
Director, Wolfson Institute of Population Health
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jack Cuzick led IBIS-I and IBIS-II, the landmark trials of tamoxifen and anastrozole for breast cancer prevention, and developed the widely used Tyrer-Cuzick breast cancer risk model. He directs the Wolfson Institute of Population Health at Queen Mary.
Share:
🧪Research Fields 研究领域
IBIS-I
IBIS-II
anastrozole prevention
Tyrer-Cuzick risk model
HPV screening
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jack Cuzick 的研究动态
Follow Jack Cuzick's research updates
留下邮箱，当我们发布与 Jack Cuzick（Queen Mary University of London）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment